Opposing regulation of histamine-induced calcium signaling by sodium selenite and ebselen via alterations of thiol redox status

European Journal of Pharmacology

Volumn 626, Issue 2-3, 2010, Pages 276-282

  Zhang, Huihui ^a   Zhong, Liangwei ^a  

^a UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Calcium signaling; Ebselen; Histamine; Sodium selenite; Thioredoxin reductase

Indexed keywords

AUROTHIOGLUCOSE; EBSELEN; HISTAMINE H1 RECEPTOR; PEROXIDASE; REACTIVE OXYGEN METABOLITE; SELENIUM; SODIUM SELENITE; THIOREDOXIN REDUCTASE;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MODIFICATION; HUMAN; HUMAN CELL; OXIDATION REDUCTION STATE; PRIORITY JOURNAL;

ANIMALS; AZOLES; CALCIUM SIGNALING; CELL LINE; DISULFIDES; HISTAMINE; ORGANOSELENIUM COMPOUNDS; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; RECEPTORS, HISTAMINE H1; SODIUM SELENITE; SULFHYDRYL COMPOUNDS;

EID: 70649083159     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.09.034     Document Type: Article

References (52)

1. Anema S.M., Walker S.W., Howie A.F., Arthur J.R., Nicol F., and Beckett G.J. Thioredoxin reductase is the major selenoprotein expressed in human umbilical-vein endothelial cells and is regulated by protein kinase C. Biochem. J. 342 Pt 1 (1999) 111-117
2. Arner E.S., and Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267 (2000) 6102-6109
3. Asako H., Kurose I., Wolf R., DeFrees S., Zheng Z.L., Phillips M.L., Paulson J.C., and Granger D.N. Role of H1 receptors and P-selectin in histamine-induced leukocyte rolling and adhesion in postcapillary venules. J. Clin. Invest. 93 (1994) 1508-1515
4. 2+-pump isoform SERCA3a is more resistant to superoxide damage than SERCA2b. Mol. Cell. Biochem. 203 (2000) 17-21
5. Carman-Krzan M. The effect of group selective reagents N-ethylmaleimide and dithiothreitol on histamine H1-receptor binding sites in the vascular smooth muscle membranes. Agents Actions 14 (1984) 561-565
6. Clejan S., Japa S., Clemetson C., Hasabnis S.S., David O., and Talano J.V. Blood histamine is associated with coronary artery disease, cardiac events and severity of inflammation and atherosclerosis. J. Cell. Mol. Med. 6 (2002) 583-592
7. Cotgreave I.A., Duddy S.K., Kass G.E., Thompson D., and Moldeus P. Studies on the anti-inflammatory activity of ebselen. Ebselen interferes with granulocyte oxidative burst by dual inhibition of NADPH oxidase and protein kinase C?. Biochem. Pharmacol. 38 (1989) 649-656
8. Daiber A., Zou M.H., Bachschmid M., and Ullrich V. Ebselen as a peroxynitrite scavenger in vitro and ex vivo. Biochem. Pharmacol. 59 (2000) 153-160
9. Dickenson J.M., and Hill S.J. Selective potentiation of histamine H1-receptor stimulated calcium responses by 1, 4-dithiothreitol in DDT1MF-2 cells. Biochem. Pharmacol. 48 (1994) 1721-1728
10. Dimmeler S., Brune B., and Ullrich V. Ebselen prevents inositol (1, 4, 5)-trisphosphate binding to its receptor. Biochem. Pharmacol. 42 (1991) 1151-1153
11. Dolor R.J., Hurwitz L.M., Mirza Z., Strauss H.C., and Whorton A.R. Regulation of extracellular calcium entry in endothelial cells: role of intracellular calcium pool. Am. J. Physiol., Cell Physiol. 262 (1992) C171-C181
12. Donaldson J., and Hill S.J. 1, 4-Dithiothreitol-induced changes in histamine H1-agonist efficacy and affinity in the longitudinal smooth muscle of guinea-pig ileum. Br. J. Pharmacol. 90 (1987) 263-271
13. Drake E.N. Cancer chemoprevention: selenium as a prooxidant, not an antioxidant. Med. Hypotheses 67 (2006) 318-322
14. Flores-Mateo G., Navas-Acien A., Pastor-Barriuso R., and Guallar E. Selenium and coronary heart disease: a meta-analysis. Am. J. Clin. Nutr. 84 (2006) 762-773
15. Gabryel B., and Malecki A. Ebselen attenuates oxidative stress in ischemic astrocytes depleted of glutathione. Comparison with glutathione precursors. Pharmacol. Rep. 58 (2006) 381-392
16. Goldhaber J.I. Free radicals enhance Na+/Ca2+ exchange in ventricular myocytes. Am. J. Physiol., Heart Circ. Physiol. 271 (1996) H823-H833
17. Gromer S., Arscott L.D., Williams C.H.J., Schirmer R.H., and Becker K. Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds. J. Biol. Chem. 273 (1998) 20096-20101
18. Hill K.E., McCollum G.W., and Burk R.F. Determination of thioredoxin reductase activity in rat liver supernatant. Anal. Biochem. 253 (1997) 123-125
19. Hirano N., Shibasaki F., Kato H., Sakai R., Tanaka T., Nishida J., Yazaki Y., Takenawa T., and Hirai H. Molecular cloning and characterization of a cDNA for bovine phospholipase C-alpha: proposal of redesignation of phospholipase C-alpha. Biochem. Biophys. Res. Commun. 204 (1994) 375-382
20. Holmgren A. Thioredoxin. Ann. Rev. Biochem. 54 (1985) 237-271
21. Holmgren A. Thioredoxin and glutaredoxin system. J. Biol. Chem. 264 (1989) 13963-13966
22. Howl J., Mondszein R.M., and Wheatley M. Characterization of G protein-coupled receptors expressed by ECV304 human endothelial cells. Endothelium 6 (1998) 23-32
23. Jones D.A., Abbassi O., McIntire L.V., McEver R.P., and Smith C.W. P-selectin mediates neutrophil rolling on histamine-stimulated endothelial cells. Biophys. J. 65 (1993) 1560-1569
24. Klotz L.O., and Sies H. Defenses against peroxynitrite: selenocompounds and flavonoids. Toxicol. Lett. 140-141 (2003) 125-132
25. Kuo S.Y., Jiann B.P., Lu Y.C., Chang H.T., Chen W.C., Huang J.K., and Jan C.R. Thiol oxidation by 2, 2′-dithiodipyridine induced calcium mobilization in MG63 human osteosarcoma cells. Life Sci. 72 (2003) 1733-1743
26. Leurs R., Bast A., and Timmerman H. Essential thiol and disulphide groups in the histamine H1-receptor signal transfer of guinea-pig parenchymal lung strips. Agents Actions 30 (1990) 169-173
27. Lewin M.H., Arthur J.R., Riemersma R.A., Nicol F., Walker S.W., Millar E.M., Howie A.F., and Beckett G.J. Selenium supplementation acting through the induction of thioredoxin reductase and glutathione peroxidase protects the human endothelial cell line EAhy926 from damage by lipid hydroperoxides. Biochim. Biophys. Acta 1593 (2002) 85-92
28. Lundstrom J., and Holmgren A. Protein disulfide-isomerase is a substrate for thioredoxin reductase and has thioredoxin-like activity. J. Biol. Chem. 265 (1990) 9114-9120
29. Madjid M., Awan I., Willerson J.T., and Casscells S.W. Leukocyte count and coronary heart disease: implications for risk assessment. J. Am. Coll. Cardiol. 44 (2004) 1945-1956
30. Meij J.T., Suzuki S., Panagia V., and Dhalla N.S. Oxidative stress modifies the activity of cardiac sarcolemmal phospholipase C. Biochim. Biophys. Acta 1199 (1994) 6-12
31. Miyazawa N., Watanabe S., Matsuda A., Kondo K., Hashimoto H., Umemura K., and Nakashima M. Role of histamine H1 and H2 receptor antagonists in the prevention of intimal thickening. Eur. J. Pharmacol. 362 (1998) 53-59
32. Muller A., Cadenas E., Graf P., and Sies H. A novel biologically active seleno-organic compound-I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (ebselen). Biochem. Pharmacol. 33 (1984) 3235-3239
33. 2-induced c-Jun NH2-terminal kinase activation and apoptosis. Mol. Biol. Cell 18 (2007) 3903-3913
34. Navas-Acien A., Bleys J., and Guallar E. Selenium intake and cardiovascular risk: what is new?. Curr. Opin. Lipidol. 19 (2008) 43-49
35. Putney J.W.J., Broad L.M., Braun F.J., Lievremont J.P., and Bird G.S. Mechanisms of capacitative calcium entry. J. Cell Sci. 114 (2001) 2223-2229
36. Sarma B.K., and Mugesh G. Glutathione peroxidase (GPx)-like antioxidant activity of the organoselenium drug ebselen: unexpected complications with thiol exchange reactions. J. Am. Chem. Soc. 127 (2005) 11477-11485
37. Satoh T., Sugama K., Matsuo A., Kato S., Ito S., Hatanaka M., and Sasaguri Y. Histamine as an activator of cell growth and extracellular matrix reconstruction for human vascular smooth muscle cells. Atherosclerosis 110 (1994) 53-61
38. Schewe T. Molecular actions of ebselen-an antiinflammatory antioxidant. Gen. Pharmacol. 26 (1995) 1153-1169
39. Schilling W.P., Cabello O.A., and Rajan L. Depletion of the inositol 1, 4, 5-trisphosphate-sensitive intracellular Ca2+ store in vascular endothelial cells activates the agonist-sensitive Ca(2+)-influx pathway. Biochem. J. 284 Pt 2 (1992) 521-530
40. Suda K., Rothen-Rutishause B., Gunthert M., and Wunderli-Allenspa H. Phenotypic characterization of human umbilical vein endothelial (ECV304) and urinary carcinoma (T24) cells: endothelial versus epithelial features. In Vitro Cell. Dev. Biol., Anim. 37 (2001) 505-514
41. Suzuki Y., Yoshimaru T., Matsui T., Inoue T., Niide O., Nunomura S., and Ra C. Fc epsilon RI signaling of mast cells activates intracellular production of hydrogen peroxide: role in the regulation of calcium signals. J. Immunol. 171 (2003) 6119-6127
42. Takagishi T., Sasaguri Y., Nakano R., Arima N., Tanimoto A., Fukui H., and Morimatsu M. Expression of the histamine H1 receptor gene in relation to atherosclerosis. Am. J. Pathol. 146 (1995) 981-988
43. Tanimoto A., Sasaguri Y., and Ohtsu H. Histamine network in atherosclerosis. Trends Cardiovasc. Med. 16 (2006) 280-284
44. Thors B., Halldorsson H., and Thorgeirsson G. Thrombin and histamine stimulate endothelial nitric-oxide synthase phosphorylation at Ser1177 via an AMPK mediated pathway independent of PI3K-Akt. FEBS Lett. 573 (2004) 175-180
45. Tiegs G., Kusters S., Kunstle G., Hentze H., Kiemer A.K., and Wendel A. Ebselen protects mice against T cell-dependent, TNF-mediated apoptotic liver injury. J. Pharmacol. Exp. Ther. 287 (1998) 1098-1104
46. Yin D., Kuczera K., and Squier T.C. The sensitivity of carboxyl-terminal methionines in calmodulin isoforms to oxidation by H(2)O(2) modulates the ability to activate the plasma membrane Ca-ATPase. Chem. Res. Toxicol. 13 (2000) 103-110
47. Ying J., Tong X., Pimentel D.R., Weisbrod R.M., Trucillo M.P., Adachi T., and Cohen R.A. Cysteine-674 of the sarco/endoplasmic reticulum calcium ATPase is required for the inhibition of cell migration by nitric oxide. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 783-790
48. Yoshizumi M., Kogame T., Suzaki Y., Fujita Y., Kyaw M., Kirima K., Ishizawa K., Tsuchiya K., Kagami S., and Tamaki T. Ebselen attenuates oxidative stress-induced apoptosis via the inhibition of the c-Jun N-terminal kinase and activator protein-1 signalling pathway in PC12 cells. Br. J. Pharmacol. 136 (2002) 1023-1032
49. Zembowicz A., Hatchett R.J., Radziszewski W., and Gryglewski R.J. Inhibition of endothelial nitric oxide synthase by ebselen. Prevention by thiols suggests the inactivation by ebselen of a critical thiol essential for the catalytic activity of nitric oxide synthase. J. Pharmacol. Exp. Ther. 267 (1993) 1112-1118
50. Zhao R., Masayasu H., and Holmgren A. Ebselen: a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 8579-8584
51. Zheng Y., Zhong L., and Shen X. Effect of selenium-supplement on the calcium signaling in human endothelial cells. J. Cell. Physiol. 205 (2005) 97-106
52. Zhong L., and Holmgren A. Essential role of selenium in the catalytic activities of mammalian thioredoxin reductase revealed by characterization of recombinant enzymes with selenocysteine mutation. J. Biol. Chem. 275 (2000) 18121-18128